Ganeden Biotech’s GanedenBC30 (Bacillus coagulans GBI-30, 6086) recently became the first probiotic to have a monograph published in the Food Chemical Codex (FCC) from the U.S. Pharmacopeial Convention (USP).

September 3, 2014

1 Min Read
USP Issues Monograph for Ganeden Probiotic

CLEVELAND—Ganeden Biotech’s GanedenBC30 (Bacillus coagulans GBI-30, 6086) recently became the first probiotic to have a monograph published in the Food Chemical Codex (FCC) from the U.S. Pharmacopeial Convention (USP).

Now, there are strain specific standards for testing the identity, concentration and purity of the probiotic, GanedenBC30.  The probiotic monograph is the first of its kind, and due to the unique characteristics of food ingredients made with live organisms and the variances between each probiotic strain, this monograph is specific to the strain Bacillus coagulans GBI-30, 6086 (GanedenBC30).

The USP is a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of ingredients manufactured, distributed and consumed to help safeguard our food supply. Enforced by FDA, these standards are recognized in more than 140 countries to help limit the introduction of potential contaminants at the ingredient level, and they serve as a widely acknowledged benchmark in the buying and selling of food ingredients in the global marketplace.

The USP standards are housed in the FCC, a reference guide with the vital measures and analytical methods to validate and determine the quality of food ingredients. The FCC monographs assist manufacturers in ensuring that ingredients are genuine, therefore assuring consumers of a safe food supply chain. This is an asset to consumers and both suppliers and manufacturers in the food industry.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like